Advances in Neurodevelopmental Disorders is a leading peer-reviewed journal published by SpringerNature, focusing on the critical intersection of psychology and social sciences as they pertain to neurodevelopmental disorders. With its ISSN 2366-7532 and E-ISSN 2366-7540, this journal has carved out a significant niche since its inception in 2017, particularly recognized for its influence in academia, evident from its category quartiles in 2023, which rank it Q3 in Psychology and Q2 in Social Sciences. The journal is committed to disseminating innovative research and knowledge that advance our understanding of neurodevelopmental disorders, making it an essential resource for researchers, professionals, and students dedicated to this field. With increasing citations and a respectable Scopus ranking—#209 in Social Sciences and #46 in Psychology—the journal continues to foster interdisciplinary dialogue and scientific advancement. Based in the Netherlands and published out of London, it offers a platform for open access to significant findings and discussions related to neurodevelopmental challenges, addressing a vital area of health that impacts individuals and families worldwide.

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, published by Springer/Plenum Publishers, is a premier academic journal dedicated to advancing knowledge in the field of autism and related developmental disorders. With an impressive impact factor reflecting its reputation for rigorous peer-reviewed research, this journal has firmly established itself within the Q1 category of Developmental and Educational Psychology, ranked #32 out of 360 journals in its category, placing it in the top 91st percentile. The journal covers a broad range of topics, including intervention strategies, developmental trajectories, and the neurobiology behind autism spectrum disorders, making it an essential resource for researchers, educators, and clinicians alike. Since its inception in 1979, the journal has maintained a commitment to disseminating significant findings that can contribute to better understanding and support for individuals with developmental disorders, promoting interdisciplinary dialogue and collaboration. While it is not offered as open access, the Journal of Autism and Developmental Disorders remains a vital platform for the dissemination of transformative research in this crucial area.

Research in Autism Spectrum Disorders, an esteemed journal published by ELSEVIER SCI LTD, is dedicated to advancing the understanding of autism spectrum disorders through innovative research and scholarly articles. Since its inception in 2007, the journal has carved out a distinguished place in the field, reflected in its robust 2023 Impact Factor and Q2 ranking in key categories such as Clinical Psychology, Developmental and Educational Psychology, and Psychiatry and Mental Health. By bridging the gap between research and practice, this journal serves as a vital resource for researchers, professionals, and students alike, fostering collaboration and knowledge-sharing among those dedicated to improving outcomes for individuals with autism. Featuring a broad scope that encompasses various aspects of autism research, the journal remains committed to publishing high-quality studies that drive the conversation forward in this critical area of study. Access options for the journal's content are available under the Elsevier guidelines, ensuring that pivotal research reaches a wide audience.

Autism Research, published by WILEY, is a premier academic journal dedicated to advancing the understanding of autism spectrum disorders (ASD) through high-quality research and clinical studies. With the ISSN 1939-3792 and E-ISSN 1939-3806, this journal has been integral to the field since its inception in 2008 and has been consistently ranked in the Q1 quartile across categories such as Genetics (clinical), Neurology (clinical), and various facets of Neuroscience. Holding prominent Scopus ranks, including #18 in Genetics (clinical) and #26 in General Neuroscience, Autism Research provides a vital platform for researchers, clinicians, and students alike to disseminate innovative findings and foster collaborations aimed at improving diagnosis and treatment strategies for individuals with autism. While not an open access journal, it offers a blend of insightful articles and impactful research that is essential for professionals seeking to stay at the forefront of this rapidly evolving field.

Developmental Neurorehabilitation is an esteemed journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental neuroscience and rehabilitation. With an ISSN of 1751-8423 and an E-ISSN of 1751-8431, this journal serves as a vital resource for researchers, clinicians, and students interested in innovative therapeutic approaches and rehabilitation techniques for children and adolescents. Since its inception in 1997, Developmental Neurorehabilitation has focused on disseminating high-quality research, contributing to a deeper understanding of recovery processes in developmental disorders, and facilitating interdisciplinary dialogue among professionals. With its recognition in Q2 and Q3 quartiles across prominent categories such as Pediatrics and Rehabilitation, it stands out as a pivotal publication in its field, boasting Scopus rankings that reflect its significant impact—ranked #53 in Rehabilitation and #139 in Pediatrics, among others. While maintaining a commitment to quality research, the journal does not currently offer open access but remains accessible through institutional subscriptions, further enriching the academic landscape with critical insights into rehabilitation methodologies for developmental challenges and promoting better clinical practices to improve patient outcomes.

Current Developmental Disorders Reports, published by SPRINGERNATURE, is a crucial resource for researchers, practitioners, and students in the fields of developmental psychology, psychiatry, and neuroscience. Since its inception in 2014, this journal has aimed to disseminate cutting-edge research on the multifaceted nature of developmental disorders, providing valuable insights into causation, diagnosis, and intervention strategies. With an E-ISSN of 2196-2987 and a notable standing in the Q3 quartile across multiple fields—developmental and educational psychology, developmental neuroscience, and psychiatry and mental health—this journal holds a significant position in the academic landscape. Researchers contributing to the journal benefit from its open access policies, stimulating knowledge sharing and dialogue within the scientific community. The journal’s commitment to advancing understanding in these critical areas of study is reflected in its rigorous publication standards and diverse range of articles, making it an essential read for anyone invested in the developments in mental health and developmental disorders.

Life Span and Disability is a pioneering open-access journal dedicated to advancing knowledge in the realms of life-span studies, developmental psychology, and health sciences. Published by CITTA APERTA EDIZIONI SRL in Italy, this journal has been at the forefront of disseminating research since its inception in 2005, embracing open-access principles since 2009 to ensure broad accessibility to its valuable content. With an ISSN of 1721-0151 and an E-ISSN of 2035-5963, it serves as a vital resource for researchers, professionals, and educators interested in understanding the multifaceted aspects of human development and disability across the lifespan. Although currently positioned in the Q4 quartile of relevant categories in 2023, the journal provides an essential platform for emerging research, and its commitment to expanding the discourse in its fields contributes significantly to knowledge sharing and innovation. By exploring themes that intersect social sciences, psychology, and health, Life Span and Disability invites contributions that enhance our comprehension of human growth and the implications of disability, making it a critical publication for those dedicated to improving life quality through interdisciplinary research.

Autism & Developmental Language Impairments is a pioneering peer-reviewed journal published by SAGE Publications Inc that focuses on advancing the understanding of autism spectrum disorders and language impairments across the developmental spectrum. Since its inception in 2016, this open access journal has provided a platform for researchers, practitioners, and educators to disseminate innovative research findings, clinical practices, and theoretical insights, reaching a global audience. The journal is notably indexed in prestigious databases and has established its credibility with a remarkable Rank of Q2 in both Clinical Psychology and Developmental and Educational Psychology as of 2023, solidifying its importance in these vital fields. Based in the United Kingdom, it addresses crucial issues in mental health, reflecting a commitment to fostering advancements that seek to enhance the lives of individuals affected by developmental language impairments. As it converges into its next phase from 2016 to 2024, Autism & Developmental Language Impairments continues to play an essential role in bridging gaps between academia and practice, making it an invaluable resource for researchers, clinicians, and students dedicated to this critical area of study.

Eureka-Revista Cientifica de Psicologia is an esteemed academic journal dedicated to advancing the field of psychology through rigorous research and insightful contributions. Published by CDID-CENTRO DOCUMENTACION, INVESTIGACION & DIFUSION in Asuncion, Paraguay, this journal serves as a crucial platform for scholars, practitioners, and students to disseminate their findings and enrich the scientific discourse of psychology. While it operates under an open-access model, facilitating widespread access to academic knowledge, the journal is committed to publishing high-quality articles that cover various sub-disciplines within psychology, including cognitive, developmental, social, and clinical psychology. By providing a space for interdisciplinary collaboration and fostering innovative research, Eureka significantly contributes to the understanding of psychological phenomena and the application of science in real-world settings. Researchers and professionals alike can benefit from the latest insights shared within its pages, making it an invaluable resource in the psychological community.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.